Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha
US8513266B2 · kind B2 · utility
3Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2008 |
| Grant date | Aug 20, 2013 |
| Priority date | — |
| Expiry date | Jan 1, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of treating cancer by administering a compound of Formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with other cancer treatments.(Formula I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.